La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

ICU Medical Résultats passés

Passé contrôle des critères 0/6

Les bénéfices de ICU Medical ont diminué à un taux annuel moyen de -53.7%, tandis que le secteur Medical Equipment a vu ses bénéfices augmenter de en à 11.2% par an. Les revenus ont augmenté de en à un taux moyen de 16.2% par an.

Informations clés

-53.7%

Taux de croissance des bénéfices

-53.3%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie	8.9%
Taux de croissance des recettes	16.2%
Rendement des fonds propres	-3.5%
Marge nette	-3.1%
Dernière mise à jour des bénéfices	30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

Aug 18

ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

Aug 07

ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult

Jun 27

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Jun 23

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

May 09

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

Apr 26

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Mar 31

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

Jan 31

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Jan 04

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Oct 28

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Oct 07

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Aug 08

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

Jul 20

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jun 08

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

Mar 25

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Feb 23

Analysts Just Made A Significant Upgrade To Their ICU Medical, Inc. (NASDAQ:ICUI) Forecasts

Jan 28

Ventilation des recettes et des dépenses

Comment ICU Medical gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

NasdaqGS:ICUI Recettes, dépenses et bénéfices (USD Millions )
Date	Recettes	Les revenus	Dépenses G+A	Dépenses de R&D
30 Jun 24	2,304	-71	620	89
31 Mar 24	2,257	-59	612	87
31 Dec 23	2,259	-30	607	85
30 Sep 23	2,249	-28	595	86
30 Jun 23	2,294	-48	600	89
31 Mar 23	2,306	-46	608	89
31 Dec 22	2,280	-74	608	93
30 Sep 22	2,043	-39	547	83
30 Jun 22	1,781	5	468	72
31 Mar 22	1,541	41	383	61
31 Dec 21	1,316	103	303	47
30 Sep 21	1,296	109	295	46
30 Jun 21	1,279	103	291	44
31 Mar 21	1,260	94	284	43
31 Dec 20	1,271	87	284	43
30 Sep 20	1,266	81	281	44
30 Jun 20	1,255	83	276	46
31 Mar 20	1,264	87	277	47
31 Dec 19	1,266	101	277	49
30 Sep 19	1,291	73	283	50
30 Jun 19	1,311	47	294	51
31 Mar 19	1,359	55	308	53
31 Dec 18	1,400	29	320	53
30 Sep 18	1,430	86	321	53
30 Jun 18	1,446	86	321	53
31 Mar 18	1,417	18	324	52
31 Dec 17	1,293	69	302	51
30 Sep 17	1,018	28	249	40
30 Jun 17	772	47	195	31
31 Mar 17	537	101	132	21
31 Dec 16	379	63	89	13
30 Sep 16	372	59	89	14
30 Jun 16	361	56	87	15
31 Mar 16	348	53	85	15
31 Dec 15	340	45	83	16
30 Sep 15	329	47	81	17
30 Jun 15	321	37	83	18
31 Mar 15	316	29	87	19
31 Dec 14	307	26	89	18
30 Sep 14	306	32	89	17
30 Jun 14	311	37	90	15
31 Mar 14	311	38	89	14
31 Dec 13	312	40	89	12
30 Sep 13	318	39	89	11

Des revenus de qualité: ICUI n'est actuellement pas rentable.

Augmentation de la marge bénéficiaire: ICUI n'est actuellement pas rentable.

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: ICUI n'est pas rentable et les pertes ont augmenté au cours des 5 dernières années à un rythme de 53.7% par an.

Accélération de la croissance: Impossible de comparer la croissance des bénéfices de ICUI au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable

Bénéfices par rapport au secteur d'activité: ICUI n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Medical Equipment ( 5.5% ).

Rendement des fonds propres

ROE élevé: ICUI a un retour sur capitaux propres négatif ( -3.47% ), car il n'est actuellement pas rentable.

ICU Medical Résultats passés

Passé contrôle des critères 0/6

Informations clés

Mises à jour récentes des performances passées

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. to Report Q2, 2024 Results on Aug 07, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Recent updates

Price target increased by 10% to US$155

CEO & Chairman of the Board exercised options and sold US$896k worth of stock

Insider recently sold US$408k worth of stock

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

CEO & Chairman of the Board exercised options and sold US$807k worth of stock

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. Updates Earnings Guidance for the Fiscal Year 2024

ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

Insufficient new directors

ICU Medical, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Now 21% undervalued

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell 1000 Dynamic Index

ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Chief Operating Officer recently sold US$1.3m worth of stock

Consensus EPS estimates fall by 65%

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

ICU Medical, Inc., Annual General Meeting, May 15, 2024

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

CEO & Chairman of the Board exercised options and sold US$262k worth of stock

ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director

Director notifies of intention to sell stock

Chief Operating Officer recently sold US$1.5m worth of stock

ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Chairman of the Board exercised options and sold US$5.4m worth of stock

ICU Medical, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care (Sector)

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 24% to US$154

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

ICU Medical, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Chief Operating Officer recently sold US$884k worth of stock

Chief Operating Officer notifies of intention to sell stock

ICU Medical Inc. Receives FDA Clearance for Plum Duo Infusion Pump and LifeShield Infusion Safety Software

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

ICU Medical, Inc. to Report Q2, 2023 Results on Aug 07, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Now 23% undervalued after recent price drop

CEO & Chairman of the Board notifies of intention to sell stock

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Small Cap Comp Growth Index

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

CEO & Chairman of the Board exercised options and sold US$3.9m worth of stock

First quarter 2023 earnings: EPS misses analyst expectations

Corporate VP notifies of intention to sell stock

Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

CEO & Chairman of the Board exercised options and sold US$1.5m worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical, Inc. to Report Q4, 2022 Results on Feb 27, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Corporate VP notifies of intention to sell stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

ICU Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2022

ICU Medical, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Director exercised options to buy US$12m worth of stock.

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical Hit Hard As Smiths Medical Needs Significant TLC

Consensus EPS estimates fall by 326%

Price target decreased to US$221

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M